Business Wire

MA-VERACODE

30.7.2024 14:53:34 CEST | Business Wire | Press release

Share
Veracode Launches Enhanced Velocity™ Partner Program and Unveils Technical Certification Program

Veracode, a global leader in application risk management, today announced the launch of its enhanced Veracode® Velocity™ Partner Program. The program enables new collaboration opportunities, empowering partners with innovative and comprehensive application and cloud risk management solutions across North America, LATAM, EMEA, and APAC. The expanded program introduces a simplified approach to working with resellers and value-added distributors.

Chris Peterson, Vice President of Global Channels at Veracode, emphasized the importance of the new program, saying, "The software security industry is experiencing a massive shift, with the explosion of AI accelerating global efforts to secure software. This is changing the way many partners do business as they require even more advanced industry-wide technical capabilities. With the launch of our enhanced global partner program, we are setting a new standard for collaboration in the software security industry.”

Through the Velocity™ program, partners can more easily support their customers to build and scale secure software from code to cloud with the Veracode application risk management platform. Partners can significantly enhance their security service offerings with AI-powered remediation, actionable visibility of exploitable flaws, and easy onboarding and integration with their DevSecOps tech stack. The company’s recent acquisition of Longbow Security also broadens Veracode’s market reach through its ecosystem of strategic security providers.

The Veracode® Velocity™ Partner Program has a multitiered structure tailored to various levels of engagement and investment. Benefits include early access to Veracode products, invitations to Veracode Technical Summits and Partner Technical Advisory Council membership, participation in thought leadership programs, revenue acceleration programs, and marketing investment.

As part of the Velocity™ program, Veracode has also unveiled its enhanced Partner Technical Certification Program. This initiative provides partners with technical certification across four progressive levels, retires any requirement for Continuing Professional Education, and builds visibility of expertise with Credly badges. These new certifications will help drive partners’ services and sales.

Game-Changing Impact

Veracode's new partner program is now active, with several partners already experiencing the benefits of enhanced collaboration and support.

Traci Byrne, Head of Global Security Strategy & GTM at World Wide Technology said, "Veracode's new partner program transforms the way we engage with security solutions. The structured tiers and clear incentives allow us to align our investments directly with outcomes, benefiting both our clients and our business strategy. This program not only supports our growth but also enhances our ability to deliver comprehensive security solutions to customers more effectively."

"Our team is very excited about the enhancements to Veracode's Partner Program,” said Michelle Jones, Senior Manager of Strategic Alliances at GuidePoint Security. “The clarity and simplicity of the program allows us to focus more on delivering value and less on navigating complexities. Through our strategic partnership, we can better serve our customers and drive significant advancements in application risk management."

Clint Huffaker, Application & API Security Practice Manager at World Wide Technology, said, “The Consultant Certification initiative from Veracode is a transformative step forward for partners, providing them with a structured pathway to enhance their technical skills. It is well designed to empower partners, boosting their ability to deliver superior services and drive business.”

Peterson closed, “The enhanced program directly addresses the growing needs of our partners, providing them with a clear path to success. Our goal is always to empower partners to grow their businesses while jointly delivering superior security solutions to our customers worldwide."

For more information about Veracode and the new partner program, please visit Veracode’s website.

About Veracode

Veracode is a global leader in Application Risk Management for the AI era. Powered by trillions of lines of code scans and a proprietary AI-assisted remediation engine, the Veracode platform is trusted by organizations worldwide to build and maintain secure software from code creation to cloud deployment. Thousands of the world’s leading development and security teams use Veracode every second of every day to get accurate, actionable visibility of exploitable risk, achieve real-time vulnerability remediation, and reduce their security debt at scale. Veracode is a multi-award-winning company offering capabilities to secure the entire software development life cycle, including Veracode Fix, Static Analysis, Dynamic Analysis, Software Composition Analysis, Container Security, Application Security Posture Management, and Penetration Testing.

Learn more at www.veracode.com, on the Veracode blog, and on LinkedIn and X.

Copyright © 2024 Veracode, Inc. All rights reserved. Veracode is a registered trademark of Veracode, Inc. in the United States and may be registered in certain other jurisdictions. All other product names, brands or logos belong to their respective holders. All other trademarks cited herein are property of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240730015405/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 22:04:00 CEST | Press release

- Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex’s portfolio - - PALSONIFY®, Crinetics’ recently launched, first and only, once-daily oral therapy for adults with acromegaly has demonstrated strong and growing early uptake - - Atumelnant, a once-daily oral adrenocorticotropic hormone (ACTH) receptor antagonist in Phase 3 development for congenital adrenal hyperplasia (CAH), has shown unique and transformative potential to both normalize androgen levels and enable management of patients with physiologic levels of glucocorticoids, the true goal of CAH management; atumelnant has also demonstrated therapeutic potential in patients with Cushing’s syndrome - - Acquisition adds to Vertex’s innovation pipeline, accelerates Vertex’s revenue growth and enhances long-term earnings profile - - Vertex to host investor call today, July 6 at 4:30 p.m. ET - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and C

Ciauru Wins the Second Edition of the Reply AI Music Contest, the International Competition Dedicated to Experimentation Across AI, Music and Live Performance6.7.2026 20:30:00 CEST | Press release

The winner was announced on the Kappa FuturFestival stage, following the performances of the five finalists selected by the international jury.German duo PARAFRAME & Avis Vox received the special Reply AI Studios Grand Prix award. The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706007611/en/ The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival First place went to Ciauru, the stag

Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 20266.7.2026 15:00:00 CEST | Press release

Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced it will report earnings after market close on July 30, 2026. The company will host a conference call and webcast on that date to discuss the second quarter 2026 results and the second half 2026 outlook at 5:00 p.m. Eastern / 2:00 p.m. Pacific time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706560476/en/ Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 2026 A live webcast of the event will be available on Rimini Street’s Investor Relations site via the Rimini Street IR events link and directly via the webcast link. Dial-in participants can access the conference by dialing 1-800-836-8184. A replay of the webcast will be available for one year following the event. About Rimini Street, Inc. Rimini Street, Inc. (Nasda

Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe6.7.2026 15:00:00 CEST | Press release

Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement with Orion Corporation for intravenous (IV) nivolumab biosimilar referencing one of the world’s most widely used cancer immunotherapies to widen patient access across Europe. Nivolumab helped usher in the era of immuno-oncology, transforming the outlook for patients with cancers such as melanoma and lung cancer. As the originator approaches loss of exclusivity in Europe, this partnership aims to put a high-quality, EU-GMP-manufactured nivolumab biosimilar within reach of more patients, reducing healthcare burden. In 2025, Nivolumab recorded sales of approximately USD4.1 billion (Source: IQVIA/IMS) Europe — underscoring the scale of the opportunity. Under the agreement, Orion will hold the exclusive rights to register, market, distribute and sell the nivolumab biosimilar across Europe. Shilpa Biologicals will lead product developm

No-Loss Trading Platform UpsideOnly Surpasses 100,000 Users Within Weeks of Launch6.7.2026 14:48:00 CEST | Press release

Rapid growth shows strong demand for a new trading model where users can make market predictions without risking their own capital Perpetuals.com Ltd (Nasdaq: PDC), today announced that UpsideOnly, its risk-free trading and market prediction platform, has seen a surge in new user sign-ups, surpassing the important milestone of 100,000 traders within weeks of its launch on May 19. UpsideOnly lets users make predictions about where global equity, commodity, forex, and crypto markets are heading without ever placing a real trade themselves. Perpetuals uses its own capital to trade on the strongest signals identified by its proprietary AI. If those trades win, Perpetuals shares the profits with the users who helped generate the signal. If the trade doesn’t make money, users lose nothing. Reaching 100,000 users so quickly after launching is a reflection of the enormous demand for a platform that flips the traditional retail trading model on its head, with early platform data showing strong

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye